The Food and Drug Administration (FDA) has approved Anthelios SX, a sunscreen from L'Oreal to be sold over-the-counter (OTC) for the prevention of sunburn and for protection against ultraviolet B (UVB) and
GlaxoSmithKline (GSK) today announced headline data showing that its H5N1 pandemic flu vaccine achieved a high immune response at a low dose of antigen. The vaccine, which uses a proprietary adjuva
The UK National Institute for Health and Clinical Excellence (NICE) has today issued guidance for the use of the targeted biological therapies, Enbrel (etanercept) and Raptiva (efalizumab), to treat a
Schering-Plough Corporation today announced that the European Commission has approved the use of Remicade (infliximab) as monotherapy in the treatment of active and progressive psoriatic arthri
According to the manufacturer the latest bird flu vaccine is more than 80% effective in protecting people against the virus.GlaxoSmithkline says it's vaccine which was produced from an inactivated
People will now be able to get better protection from the sun with a new sunscreen recently approved by the U.S. Food and Drug Administration (FDA).The new product, Anthelios SX, made by
The Food and Drug Administration in the U.S. has issued a warning against drinking or injecting high-strength hydrogen peroxide products to treat serious diseases such as AIDS.The agency is warning
The Department of Health and Human Services (HHS) has announced it will purchase 10,000 therapeutic courses of treatment of Anthrax Immune Globulin (AIG) from Cangene Corporation of Winnipeg, Manitoba, Canada for a total of $143,833,719. This a
A new "smart" cancer drug will be available to patients in Britain today which works by deploying two chemical 'bullets' that attack specific molecular targets, starving tumours of nutrients and inhibiting the enzyme that signals cells to multiply.
After years of dilly dallying over it's stand on over-the-counter sales of the "morning-after" contraceptive officials at the U.S. Food and Drug Administration (FDA) suddenly appear to be doing an about tu
Date: Wednesday, 13-Sep-2006
The strict regulations governing the prescription and use of the acne drug isotretinoin, sold by Roche under the brand name Accutane, are affecting the drug's sale and dispensation and raising concerns about sales of the medication over the Internet, the Wall Street Journal reports (Corbett Dooren, Wall Street Journal, 9/12).Studies have shown that isotretinoin can cause severe side effects in pregnant women, such as birth defects and fetal death, and also might cause depression and suicide.
FDA in 2004 released data that showed that strict measures enacted to reduce the number of birth defects related to isotretinoin had little effect on the number of women who take the drug while pregnant.
The agency on Dec. 30, 2005, began to register physicians, prescription drug wholesalers, pharmacists and women into iPledge, which requires that women submit two negative pregnancy tests before they can receive an initial prescription for isotretinoin.
In addition, women must undergo a monthly pregnancy test before each monthly refill and must agree to either use two forms of birth control at the same time or to abstain from intercourse for one month prior to treatment with isotretinoin, during treatment and for one month after treatment has ended, according to FDA.
Women also must sign a document to acknowledge that isotretinoin can increase risk for birth defects, depression and suicidal thoughts.
About 165,000 people have registered with iPledge, which is administered together with companies that sell the drug.
However, critics say that iPledge is poorly administered (Kaiser Daily Women's Health Policy Report, 9/5).
Isotretinion is one of about two dozen drugs prescribed under a "restricted-access plan intended to curb misuse or unnecessary side effects," the Journal reports.
According to the IMS Health, a company that tracks prescription drug sales, the number of Accutane prescriptions in the first half of 2006 decreased by 46% compared with the same period in 2005, and prescriptions for the leading generic version fell by 16% in the same time period.
iPledge "may turn into something of a referendum" on FDA's "ability to manage the risks and benefits of powerful drugs," the Journal reports.
To discourage people from purchasing isotretinoin online, FDA in the next six months is expected to discuss with drug manufacturers ways to change iPledge, including making required monthly physician visits more flexible and easing the requirement that patients obtain the medication within seven days after it is prescribed.
In addition, FDA is creating a Web site that aims to "pop up" when isotretinoin is typed into a search engine to discourage people from purchasing the drug over the Internet (Wall Street Journal, 9/12).
This article is republished with kind permission from our friends at the The Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery of in-depth coverage of health policy developments, debates and discussions. The Kaiser Daily Health Policy Report is published for Kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. Copyright 2006 Advisory Board Company and Kaiser Family Foundation. All rights reserved.